Hikma Pharmaceutical | HIK - Nettoeinkommen





Nettoeinkommen Veränderung Datum
Almirall EUR 19.58M 7M 2025-12
argenx SE USD 472M 106M 2026-06
AstraZeneca USD 2.51B 573M 2026-06
Autolus Therapeutics Ltd USD -71.6M 18.73M 2026-03
Bayer EUR 219M 2.54B 2026-06
Fresenius EUR 382M 53M 2026-06
Genmab DKK 303M 250M 2026-06
GlaxoSmithKline GBP 435M 1.3B 2026-06
GRIFOLS EUR 154M 81M 2026-06
Hikma Pharmaceutical USD 164M 45M 2025-12
Lakefront Biotherapeutics EUR 2.11M 12.38M 2026-06
Lonza CHF 426M 119M 2025-06
Merck EUR 490M 169M 2026-06
Orion EUR 140.2M 49.8M 2026-06
Recordati EUR 116.61M 36.45M 2026-06
Roche Holding CHF 6.87B 1.4B 2026-06
Sanofi EUR 343M 1.27B 2026-06
UCB EUR 1.08B 608M 2025-12